---
title: "Citic Securities Sticks to Its Buy Rating for 3SBio (TRSBF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305414304.md"
description: "Citic Securities analyst maintained a Buy rating on 3SBio on November 11 and set a price target of HK$30.00. The company’s shares closed last Friday at HK$14.97.3SBio has an analyst consensus of Strong Buy, with a price target consensus of HK$28.08, an 87.60% upside from current levels. In a report released on October 29, CMB International Securities also maintained a Buy rating on the stock with a HK$34.78 price target."
datetime: "2026-11-13T05:15:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305414304.md)
  - [en](https://longbridge.com/en/news/305414304.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305414304.md)
generator: "portal-rs"
---

# Citic Securities Sticks to Its Buy Rating for 3SBio (TRSBF)

Citic Securities analyst maintained a Buy rating on 3SBio on November 11 and set a price target of HK$30.00. The company’s shares closed last Friday at HK$14.97.

3SBio has an analyst consensus of Strong Buy, with a price target consensus of HK$28.08, an 87.60% upside from current levels. In a report released on October 29, CMB International Securities also maintained a Buy rating on the stock with a HK$34.78 price target.

### Related Stocks

- [01530.HK](https://longbridge.com/en/quote/01530.HK.md)

## Related News & Research

- [UBS Keeps Their Buy Rating on 3SBio (TRSBF)](https://longbridge.com/en/news/303823090.md)
- [Shenwan Hongyuan Keeps Their Buy Rating on 3SBio (TRSBF)](https://longbridge.com/en/news/299506729.md)
- [Citi: 2026 NRDL Negotiation Results Released; Drugmakers Say Price Cuts Mild and Manageable](https://longbridge.com/en/news/306083646.md)
- [MPCM Sticks to Their Buy Rating for PORR AG (0J04)](https://longbridge.com/en/news/306341079.md)
- [Tamil Nadu Newsprint and Papers' (NSE:TNPL) Profits Appear To Have Quality Issues](https://longbridge.com/en/news/306343812.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**